ALXO
ALXO
US00166B1052
ALX Oncology Holdings Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
100.846.000 142.467.000
29.2%
Operating Income -100.846.000 -142.467.000
29.2%
Pretax Income -101.695.000 -134.850.000
24.6%
Net Income Common Stockholders -101.695.000 -134.850.000
24.6%
-- --
--
-- --
--
ende